Patents by Inventor Darryl Davis

Darryl Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11795434
    Abstract: There is disclosed a cardiac explant-derived stem cell (EDC), the cell comprising a gene encoding an intermediate-conductance Ca2+-activated K+ channel, and wherein the gene causes an overexpression of the intermediate-conductance Ca2+-activated K+ channel, and methods of producing same. There is also disclosed a method of producing engineered EDCs having a modulated bioelectric property, the method comprising: obtaining EDCs; introducing a KCNN4 gene into the EDCs to increase the expression of KCa3.1 channels, to produce engineered EDCs. There is also disclosed a composition for treating or ameliorating a damaged myocardium in a subject, the composition comprising extracellular vesicles isolated from cultures of engineered EDCs. There is also disclosed a method for treating or ameliorating a damaged myocardium in a subject, comprising administering the engineered EDCs or the extracellular vesicles isolated from cultures of engineered EDCs to the damaged myocardium of the subject.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: October 24, 2023
    Assignees: Ottawa Heart Institute Research Corporation, L'Institut de Cardiologie de Montréal
    Inventors: Patrick Vigneault, Darryl Davis, Stanley Nattel, Sandrine Parent
  • Patent number: 11083756
    Abstract: Methods for generating serum-free and/or xenogen-free cardiac explant-derived stem cells (EDC) are provided. These methods may include providing an initial cardiac explant, which has been minced and digested; plating the initial cardiac explant; culturing the plated cardiac explant in serum-free and xenogen-free medium; harvesting EDC cells surrounding or emerging from the plated cardiac explant; and optionally performing static expansion of harvested EDC cells in serum-free and xenogen-free media. Serum-free and/or xenogen-free cardiac EDC cells produced by these methods, as well as methods and uses thereof for the treatment of heart failure in a subject in need thereof, are also provided.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: August 10, 2021
    Assignee: OTTAWA HEART INSTITUTE RESEARCH CORPORATION
    Inventors: Duncan J. Stewart, David Courtman, Seth Mount, Darryl Davis
  • Publication number: 20200172871
    Abstract: There is disclosed a cardiac explant-derived stem cell (EDC), the cell comprising a gene encoding an intermediate-conductance Ca2+-activated K+ channel, and wherein the gene causes an overexpression of the intermediate-conductance Ca2+-activated K+ channel, and methods of producing same. There is also disclosed a method of producing engineered EDCs having a modulated bioelectric property, the method comprising: obtaining EDCs; introducing a KCNN4 gene into the EDCs to increase the expression of KCa3.1 channels, to produce engineered EDCs. There is also disclosed a composition for treating or ameliorating a damaged myocardium in a subject, the composition comprising extracellular vesicles isolated from cultures of engineered EDCs. There is also disclosed a method for treating or ameliorating a damaged myocardium in a subject, comprising administering the engineered EDCs or the extracellular vesicles isolated from cultures of engineered EDCs to the damaged myocardium of the subject.
    Type: Application
    Filed: November 8, 2019
    Publication date: June 4, 2020
    Inventors: Patrick VIGNEAULT, Darryl DAVIS, Stanley NATTEL, Sandrine PARENT
  • Publication number: 20170340678
    Abstract: Methods for generating serum-free and/or xenogen-free cardiac explant-derived stem cells (EDC) are provided. These methods may include providing an initial cardiac explant, which has been minced and digested; plating the initial cardiac explant; culturing the plated cardic explant in serum-free and xenogen-free medium; harvesting EDC cells surrounding or emerging from the plated cardiac explant; and optionally performing static expansion of harvested EDC cells in serum-free and xenogen-free media. Serum-free and/or xenogen-free cardiac EDC cells produced by these methods, as well as methods and uses thereof for the treatment of heart failure in a subject in need thereof, are also provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: November 30, 2017
    Inventors: Duncan J. Stewart, David Courtman, Seth Mount, Darryl Davis
  • Patent number: 7057501
    Abstract: A tailgate warning system, for use in a target vehicle, for determining unsafe following and followed distances, having a front rangefinder, a rear rangefinder, a vehicle speed sensor, incident memory, hazard lights, and a control unit. When an unsafe following distance is determined by the control unit using the front rangefinder and speed sensor, a dashboard audible visual alert is activated. When an unsafe followed distance is determined by the control unit using the rear rangefinder and speed sensor, the dashboard audible visual alert and the hazard lights are activated. Incidents of tailgating are recorded in the incident memory.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: June 6, 2006
    Inventor: Darryl Davis
  • Patent number: 5381624
    Abstract: The present device relates to an agricultural chemical applicator for applying herbicides. The system is activated by a sensor bar having a plurality of conductive wire rod sensors. When a sensor contacts an unwanted plant, a detector and control circuit detects the current leakage and activates a time delay circuit which uses two timers in series and an opto-isolator to activate a solenoid valve. When a particular sensor is activated, a particular valve will be opened, thereby sending chemicals through a specific nozzle. Each sensor has its own circuit and its own nozzles.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: January 17, 1995
    Inventors: D. Darryl Davis, Marlin H. Anderson, Jr.